USDA, ARS, Western Human Nutrition Research Center
Davis, California, 95616, United States
NCT Number: NCT06107231
The purpose of this research is to compare two snacks, one with honey and nuts and the other with sugar and nuts, on glucose levels before and after eating these snacks.
The investigators hypothesize that honey and nuts will have an additive effect on the reduction of postprandial glucose response. The investigators further hypothesize that consumption of honey paired with nuts will retain the benefit of sugar consumption in satiety and reduction of metabolic stress.
This study is active but is not currently recruiting participants.
Notify Me18 year–40 year
All sexes
Interventional
Not applicable
Davis, California, 95616, United States
Consuming sugar creates a feeling of satiation, and may buffer metabolic stress. However, prolonged postprandial hyperglycemia has been identified as a potential risk factor in type 2 diabetes and cardiovascular disease. Nuts, which are recommended to be consumed as part of a Mediterranean diet, up to 2 servings per day, have been shown to dramatically reduce postprandial glucose response to carbohydrates. Additionally, honey, which is typically used as an added sugar within a Mediterranean diet pattern, has a lower glycemic index than table sugar and may result in a reduced postprandial glucose response relative to other nutritive sweeteners. However, it is not yet known whether honey can work additively with nuts to further reduce postprandial glucose response over the reduction caused by nuts alone.
Honey has been shown to produce equivalent or greater satiety to regular table sugar and there is some indication that honey can improve immediate/working memory. Therefore, combined consumption of honey and nuts may offer a way to maximize the benefits of carbohydrate consumption on satiety and metabolic stress reduction while minimizing its negative effects on metabolism. However, it is not yet known whether sugars contained in the more complex food matrix of honey, consumed together with a food like nuts can impact satiety and metabolic stress in the way that has been observed for sugar.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Regarding female candidates:
Honey representing 7% of total energy (kilocalorie) needs (40-70 grams)
Sucrose representing 7% of total energy (kilocalorie) needs (40-70 grams)
Honey representing 7% of total energy (kilocalorie) needs (40-70 grams) plus 1 ounce almonds (28 grams)
Sucrose representing 7% of total energy (kilocalorie) needs (40-70 grams) plus 1 ounce almonds (28 grams)
Time frame: Measured continuously over days 0-8 and 23-31
Interstitial glucose response measured by a continuous glucose monitor
Time frame: Fasting and 30, 60, and 90 min after consumption of standard breakfast on days 4, 8, 27, and 31
Responses regarding hunger will be collected using a visual analog scale on a tablet with a 0-100 scale depicting the extremes (0= not at all to 100= extremely)
Time frame: Fasting and 30, 60, and 90 min after consumption of standard breakfast on days 4, 8, 27, and 31
Responses regarding fullness will be collected using a visual analog scale on a tablet with a 0-100 scale depicting the extremes (0= not at all to 100= extremely)
Time frame: Fasting and 30, 60, and 90 min after consumption of standard breakfast on days 4, 8, 27, and 31
Responses regarding desire to eat will be collected using a visual analog scale on a tablet with a 0-100 scale depicting the extremes (0= not at all to 100= extremely)
Time frame: Fasting and 30, 60, and 90 min after consumption of standard breakfast on days 4, 8, 27, and 31
Responses regarding satisfaction with snack will be collected using a visual analog scale on a tablet with a 0-100 scale depicting the extremes (0= not at all to 100= extremely)
Time frame: Fasting and 30, 60, and 90 min after consumption of standard breakfast on days 4, 8, 27, and 31
Responses regarding prospective consumption will be collected using a visual analog scale on a tablet with a 0-100 scale depicting the extremes (0= not at all to 100= extremely)
Time frame: Fasting and 30, 60, and 90 min after consumption of standard breakfast on days 4, 8, 27, and 31
Responses regarding nausea will be collected using a visual analog scale on a tablet with a 0-100 scale depicting the extremes (0= not at all to 100= extremely)
Time frame: Days 4, 8, 27, and 31
Cambridge Neuropsychological Test Automated battery (CANTAB) software will be used to assess Spatial Working Memory (SWM)
Time frame: Days 4, 8, 27, and 31
CANTAB software will be used to assess Paired Associates Learning (PAL)
Time frame: Days 4, 8, 27, and 31
CANTAB software will be used to assess Rapid Visual Processing (RVP)
Time frame: Day 0 and 23 fasting only. Days 4, 8, 27, and 31 at fasting, 30, 60 and 90 min after consumption of snack provided in standard breakfast
Metabolic stress will be analyzed by measuring cortisol in saliva samples
Time frame: Days 0, 4, 8, 23, 27,and 31 at fasting only
Passive drool will be assayed for estradiol as they impact metabolic stress throughout study days
Time frame: Days 0, 4, 8, 23, 27,and 31 at fasting only
Passive drool will be assayed for progesterone as they impact metabolic stress throughout study days
Time frame: Stool collected on study days 0, 4, 8, 23, 27, and 31
Fecal calprotectin measured in stool samples
Time frame: Stool collected on study days 0, 4, 8, 23, 27, and 31
Honey responsive genes identified by metagenomics
Time frame: Days 1-3, 5-7, 24-26, and 28-30
Food records collected using Automated Multi-pass Method (AMPM) on the platform ASA24
USDA, Western Human Nutrition Research Center
Fed
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06960967
Glucose Metabolism Disorders, Hyperinsulinism
Melbourne, Victoria, Australia
View Trial DetailsNCT05977244
Dyslipidemias, Gastric Emptying
Kuala Lumpur, Malaysia
View Trial DetailsNCT07563985
Postprandial Glycemia, Satiety
Alanya, Antalya, Turkey (Türkiye)
View Trial DetailsNCT06170905
Diabetes Mellitus, Diabetes, Gestational
Ulm, Germany
View Trial Details